KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Infinimmune, Inc., a biotechnology company pioneering human-first antibody discovery and design, announced a collaboration to advance manufacturing of Infinimmune’s lead human monoclonal antibody (“IFX-101”) program.
The first antibody in Infinimmune’s therapeutic drug development pipeline, IFX-101, targets atopic dermatitis and is designed to deliver superior efficacy with extended dosing intervals for improved patient quality of life. By sourcing antibodies directly from the human immune system, Infinimmune taps into a naturally optimized, safe, and effective therapeutic reservoir, rather than engineering from scratch. Infinimmune’s GLIMPSE™ platform – a protein language model trained solely on native human antibody sequences – learns from millions of successful immune responses to engineer superior antibodies that harness evolution-proven strategies with enhanced biologic properties. This combination creates a potent platform that’s uniquely differentiated in the biologics field.
“We are pleased to partner with KBI Biopharma to advance our lead antibody program,” said Wyatt McDonnell, Ph.D., CEO and Co-Founder, Infinimmune. “By combining our Anthrobody® and GLIMPSE™ platforms together with KBI’s development and manufacturing expertise, we’re positioned to rapidly advance toward clinical trials. Our human-first approach enables us to deliver what patients really need – more effective treatments with greater convenience. This collaboration is an important step in our mission to bring transformative, human-first antibodies to patients in need."
“KBI is proud to support Infinimmune in its effort to transform biologics and deliver safer, more effective antibody therapeutics,” said Katie Edgar, Chief Business Officer of KBI Biopharma. “Our strategic partnership will be highly synergistic in biologics development, by combining Infinimmune’s cutting-edge antibody discovery with KBI’s deep expertise in development and manufacturing capabilities.”
The IFX-101 program is progressing at KBI’s Cell Line Development Center of Excellence in Geneva, Switzerland, using KBI’s advanced monoclonal antibody development and manufacturing platform, SUREmAb™, powered by Selexis.
About Infinimmune
Infinimmune is a biotechnology company pioneering a novel approach to antibody drug discovery and development. Founded by a world-class, multidisciplinary team of scientists and technologists, Infinimmune is reinventing antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. These truly human antibodies are designed to drug new and existing targets with improved safety and efficacy. Infinimmune is building its own pipeline of drug candidates and partnering with pharmaceutical companies to advance their antibody programs, fill their pipelines, and reach new patients and new indications. To learn more, visit infinimmune.com and follow us on LinkedIn and @infinimmune.
About KBI Biopharma, Inc.
KBI Biopharma, Inc., a JSR Life Sciences company, together with its affiliates, is a global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. As a global leader in mammalian cell line development, with best-in-class modular technology and highly specialized solutions, KBI enables the life sciences industry to rapidly discover, develop, and commercialize innovative medicines and vaccines. With each of its 500+ customer partners, KBI works closely to personalize and rapidly accelerate drug development programs.
Global partners are utilizing KBI’s technologies to advance more than 170 drug candidates in preclinical and clinical development and the manufacture of ten commercial products. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, KBI delivers robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, KBI helps partners advance drug candidates to the market. KBI serves its global customers with six locations in Europe and the USA. More information is available at www.kbibiopharma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250908013845/en/
Contacts
KBI Biopharma Company Contact
David Self
KBI Biopharma, Inc.
dself@kbibiopharma.com
KBI Biopharma Media Contact
Blair Ciecko
CG Life
bciecko@cglife.com
Infinimmune Media Contact
Kimberly Ha
KKH Advisors
kimberly.ha@kkhadvisors.com917-291-5744
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mouser Electronics Explores the 3D Printing Revolution and Its Impact on Design, Engineering, and Manufacturing9.9.2025 18:11:00 EEST | Press release
Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, today released its latest installment of the Empowering Innovation Together (EIT) technology series, entitled, That's 3D Printed? This installment explores how the foundational principles of 3D printing, also known as additive manufacturing, have advanced to transform design, engineering, and manufacturing through novel materials, artificial intelligence (AI), accelerated production cycles, and unparalleled design precision. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909696607/en/ Discover how additive manufacturing transforms design, accelerates production, and unlocks new possibilities...one layer at a time. The ingenuity of 3D printing lies in its ability to fabricate highly complex geometries and intricate internal structures, a feat often unachievable with conventional subtractive
Andersen Consulting Adds to Human Capital Capabilities with HAGER Executive Consulting9.9.2025 16:30:00 EEST | Press release
Andersen Consulting enhances its human capital offerings through a Collaboration Agreement with HAGER Executive Consulting, a firm specializing in board services, executive search, and leadership development. Founded in 1996, HAGER supports clients internationally across industries—including industrial, healthcare, and financial services—through executive search services and governance solutions. The firm’s approach integrates deep sector insight with its proprietary methodology focused on aligning leadership potential with business transformation. “Executive search is about more than filling a position, it’s about recognizing potential and building leadership that endures,” said Martin Krill, managing partner of HAGER. “Our services center around connecting purpose-driven leaders with organizations poised for change. Through collaboration with Andersen Consulting, we’re amplifying that mission on a global scale.” “HAGER’s reputation is built on precision, trust, and a deep understandi
Rimini Street Selected by 100+ Organizations as their Preferred Support Solution for VMware9.9.2025 16:00:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, announces a new client milestone, surpassing 100 VMware contracts served to date. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909900104/en/ Rimini Street Selected by 100+ Organizations as their Preferred Support Solution for VMware Selected by the some of the world’s leading CIOs at global organizations as their preferred VMware support partner for perpetual licenses, Rimini Support™ for VMware continues to lead the market as a powerful, proven solution for protecting and maximizing the full value of VMware investments. By partnering with Rimini Street and benefitting from the premium support, exclusive security services and expert guidance, clients are effectively lowering IT operating costs, achieving fas
Regula Hits NIST Test: The Only Vendor Recognized Among Top Performers in All Critical Age Estimation Scenarios9.9.2025 15:30:00 EEST | Press release
For the first time, Regula, a global developer of identity verification (IDV) solutions and forensic devices, has taken part in the National Institute of Standards and Technology (NIST) evaluation for age estimation. This debut could hardly be stronger: Regula achieved the best result in the test, outperforming other vendors. Crucially, Regula’s technology demonstrated consistent accuracy across a wide range of demographics, making it the most universal solution on the market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909879354/en/ Regula’s technology estimates age with unmatched precision, gaining top results in the independent NIST test In addition, Regula ranked among the top three in two of the most critical age assurance scenarios: Challenge 25 and Child Online Safety (ages 13–16). NIST is a globally respected authority in technology testing and standardization. Its Face Analysis Technology Evaluation (FATE) Age
Other World Computing to Debut New Thunderbolt 5 Dual 10GbE Network Dock Alongside Its Industry-Leading Roster of Storage and Connectivity Solutions at IBC20259.9.2025 15:30:00 EEST | Press release
Other World Computing (OWC®), a trusted leader in high-performance storage, memory, connectivity, software, and accessories that empower creative and business professionals to maximize performance, enhance reliability, and streamline workflows, today announced it will debut its new OWC Thunderbolt 5 Dual 10GbE Network Dock, as well as showcase its unrivaled roster of storage and connectivity solutions, at IBC2025, taking place September 12-15 (RAI Amsterdam). Visitors to OWC’s Booth – Hall 7, Booth 7.A60 – will have the opportunity to see first-hand a wide range of OWC storage and connectivity innovations relied on by top creative and business professionals worldwide. New Product Debuts: - OWC Thunderbolt 5 Dual 10GbE Network Dock - This powerful dock enables users to connect to multiple high-speed networks, access blazing-fast network-attached storage (NAS), and expand device setups via a single Thunderbolt cable. - OWC Express 1M2 80G - An evolutionary leap forward in portable SSD
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom